Exchange: NASDAQ·Updated 07:54 PM EDT
IDYA logo

IDYA Ideaya Biosciences Inc

$39.86
$0.11
(0.28%)
Today
Closed $39.86
$0.64
(1.61%)
After Hours
EarningsNov 9
Mkt Cap$3.86B
Vol448,008.00

About IDYA

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
43

Bearish Sentiment

How do you feel about IDYA?

Advertisement|Remove ads.